Skip to Content
Is technology key to beating breast cancer? Learn more >

Palbociclib Pregnancy and Breastfeeding Warnings

Palbociclib is also known as: Ibrance

Palbociclib Pregnancy Warnings

This drug can cause fetal harm based on findings in animals and its mechanism of action. US FDA pregnancy category: Not assigned Comments: -Advise females of reproductive potential of the potential risk to a fetus and to use effective contraception during therapy and for at least 2 weeks after the last dose. -Advise females to contact their healthcare provider if they become pregnant or if pregnancy is suspected during treatment. -Animal studies suggest this drug may compromise male fertility.

Animal studies have revealed that this drug is teratogenic and fetotoxic at maternal exposures 4 times or more the human clinical exposure (based on AUC at the recommended human dose). Embryofetal toxicities included reduced fetal body weights and increased incidence of skeletal variations. In repeat-dose toxicity studies in animals, testicular degeneration was observed at doses ranging from 0.1 to 11 times the human clinical exposure. There are no controlled data in humans.

See references

Palbociclib Breastfeeding Warnings

Discontinue breastfeeding during treatment. Excreted into human milk: Unknown Excreted into animal milk: Data not available Comments: The effects on the breastfed child are unknown; however, this drug has potential to cause serious adverse reactions in nursing infants.

See references

References for pregnancy information

  1. "Product Information. Ibrance (palbociclib)." Pfizer U.S. Pharmaceuticals Group, New York, NY.

References for breastfeeding information

  1. "Product Information. Ibrance (palbociclib)." Pfizer U.S. Pharmaceuticals Group, New York, NY.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide